Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
192M
-
Number of holders
-
402
-
Total 13F shares, excl. options
-
175M
-
Shares change
-
+3.46M
-
Total reported value, excl. options
-
$16.3B
-
Value change
-
+$328M
-
Put/Call ratio
-
0.79
-
Number of buys
-
187
-
Number of sells
-
-193
-
Price
-
$93.07
Significant Holders of BIOMARIN PHARMACEUTICAL INC - COM (BMRN) as of Q3 2017
485 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - COM as of Q3 2017.
BIOMARIN PHARMACEUTICAL INC - COM (BMRN) has 402 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 175M shares
of 192M outstanding shares and own 91.17% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (20.9M shares), VANGUARD GROUP INC (14.6M shares), JENNISON ASSOCIATES LLC (12.3M shares), BlackRock Inc. (11.9M shares), PRIMECAP MANAGEMENT CO/CA/ (9.64M shares), SANDS CAPITAL MANAGEMENT, LLC (8.06M shares), FMR LLC (8.02M shares), BAKER BROS. ADVISORS LP (5.91M shares), Invesco Ltd. (4.49M shares), and STATE STREET CORP (4.01M shares).
This table shows the top 402 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.